This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2%
lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10
years of age presenting to a pediatric emergency department with an acute frontal migraine
headache.